VICI vs. GSK.L
VICI (VICI Properties Inc.) and GSK.L (GlaxoSmithKline plc) are both stocks. VICI operates in REIT - Diversified (Real Estate), while GSK.L operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, VICI returned 1.81%/yr vs 4.98%/yr for GSK.L. At a 0.17 correlation, their price movements are largely independent.
Performance
VICI vs. GSK.L - Performance Comparison
Loading charts...
Different Trading Currencies
VICI is traded in USD, while GSK.L is traded in GBp. To make them comparable, the GSK.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, VICI achieves a -0.97% return, which is significantly lower than GSK.L's 5.71% return.
VICI
- 1D
- -1.65%
- 1M
- -4.99%
- YTD
- -0.97%
- 6M
- 1.35%
- 1Y
- -7.59%
- 3Y*
- 0.12%
- 5Y*
- 1.81%
- 10Y*
- —
GSK.L
- 1D
- -1.24%
- 1M
- 2.51%
- YTD
- 5.71%
- 6M
- 7.01%
- 1Y
- 29.39%
- 3Y*
- 18.35%
- 5Y*
- 4.98%
- 10Y*
- 4.80%
VICI vs. GSK.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VICI VICI Properties Inc. | -0.97% | 1.90% | -3.07% | 3.58% | 13.01% | 23.77% | 6.00% | 43.23% | -3.62% | 10.51% |
GSK.L GlaxoSmithKline plc | 5.71% | 52.14% | -5.11% | 10.47% | -33.85% | 25.52% | -18.33% | 30.34% | 12.28% | -9.43% |
Correlation
The correlation between VICI and GSK.L is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2017 | 0.17 |
Fundamentals
VICI:
$29.28B
GSK.L:
£77.94B
VICI:
$2.92
GSK.L:
£1.42
VICI:
9.39
GSK.L:
13.43
VICI:
0.53
GSK.L:
0.30
VICI:
7.20
GSK.L:
2.39
VICI:
1.04
GSK.L:
4.37
VICI:
$4.05B
GSK.L:
£32.78B
VICI:
$3.01B
GSK.L:
£23.84B
VICI:
$2.90B
GSK.L:
£11.56B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VICI vs. GSK.L — Risk / Return Rank
VICI
GSK.L
VICI vs. GSK.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VICI Properties Inc. (VICI) and GlaxoSmithKline plc (GSK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VICI | GSK.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -2.31 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.21 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.43 | 1.58 | -2.01 |
| Martin ratioReturn relative to average drawdown | -0.73 | 3.69 | -4.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VICI | GSK.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.46 | 1.15 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | 0.20 | -0.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.21 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.15 | +0.19 |
Drawdowns
VICI vs. GSK.L - Drawdown Comparison
The maximum VICI drawdown since its inception was -60.21%, which is greater than GSK.L's maximum drawdown of -51.16%. Use the drawdown chart below to compare losses from any high point for VICI and GSK.L.
Loading charts...
Drawdown Indicators
| VICI | GSK.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.21% | -51.16% | -9.05% |
Max Drawdown (1Y)Largest decline over 1 year | -17.88% | -18.53% | +0.65% |
Max Drawdown (3Y)Largest decline over 3 years | -17.88% | -29.30% | +11.42% |
Max Drawdown (5Y)Largest decline over 5 years | -18.61% | -51.16% | +32.55% |
Max Drawdown (10Y)Largest decline over 10 years | — | -51.16% | — |
Current DrawdownCurrent decline from peak | -15.44% | -15.20% | -0.24% |
Average DrawdownAverage peak-to-trough decline | -8.18% | -15.96% | +7.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.48% | 7.93% | +2.55% |
Volatility
VICI vs. GSK.L - Volatility Comparison
The current volatility for VICI Properties Inc. (VICI) is 4.85%, while GlaxoSmithKline plc (GSK.L) has a volatility of 5.92%. This indicates that VICI experiences smaller price fluctuations and is considered to be less risky than GSK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VICI | GSK.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.85% | 5.92% | -1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 12.56% | 18.51% | -5.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.69% | 25.56% | -8.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.97% | 24.76% | -3.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.28% | 22.99% | +6.29% |
Dividends
VICI vs. GSK.L - Dividend Comparison
VICI's dividend yield for the trailing twelve months is around 6.51%, more than GSK.L's 3.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK.L GlaxoSmithKline plc | 3.50% | 3.51% | 4.53% | 3.84% | 5.30% | 4.93% | 5.90% | 4.45% | 5.31% | 5.99% | 4.88% | 5.77% |
VICI VICI Properties Inc. | 6.51% | 6.28% | 5.80% | 5.05% | 4.63% | 4.58% | 4.92% | 4.58% | 5.31% | 0.00% | 0.00% | 0.00% |
Financials
VICI vs. GSK.L - Financials Comparison
This section allows you to compare key financial metrics between VICI Properties Inc. and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VICI vs. GSK.L - Profitability Comparison
VICI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, VICI Properties Inc. reported a gross profit of 0.00 and revenue of 1.02B. Therefore, the gross margin over that period was 0.0%.
GSK.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a gross profit of 5.75B and revenue of 7.63B. Therefore, the gross margin over that period was 75.4%.
VICI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, VICI Properties Inc. reported an operating income of 0.00 and revenue of 1.02B, resulting in an operating margin of 0.0%.
GSK.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported an operating income of 2.29B and revenue of 7.63B, resulting in an operating margin of 30.1%.
VICI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, VICI Properties Inc. reported a net income of 872.39M and revenue of 1.02B, resulting in a net margin of 85.7%.
GSK.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a net income of 1.74B and revenue of 7.63B, resulting in a net margin of 22.8%.
Frequently Asked Questions
VICI and GSK.L have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for VICI and GSK.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer